ArticleCureus2026
Choroidal Metastasis as a Presenting Feature of Lung Cancer in a Patient Presenting With Sudden-Onset Bilateral Loss of Vision: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Choroidal metastases are a rare but significant presentation of lung cancer, often indicating advanced disease and associated with poor prognosis. This report describes a 61-year-old woman with chronic obstructive pulmonary disease and a heavy smoking history who presented with sudden bilateral vision loss. Ophthalmic evaluation revealed bilateral choroidal metastases with exudative retinal detachment. Imaging identified a right hilar lung mass with widespread metastases. Due to her poor clinical status, biopsy was not feasible, and she received palliative care. She died within two weeks of presentation. This case highlights the importance of considering ocular symptoms as possible initial signs of occult and usually advanced systemic malignancy, necessitating a thorough history taking, examination and relevant investigations to identify distant malignancy and what treatment options may be offered to the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.